Study shows benefit of shunt in cirrhosis

10/18/2013 | Healio (free registration)

In a study presented at the American College of Gastroenterology meeting, placement of a transjugular portosystemic shunt led to complete portal vein recanalization among 68% of cirrhotic participants with portal vein thrombosis and significant improvement among another 20%, as measured with Doppler vascular ultrasound. "This study has brought up new ideas in the field of PVT treatment," said researcher Modaresi Esfeh.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN